Fundamentals in Focus for Strata Skin Sciences, Inc. (SSKN)

Strata Skin Sciences, Inc. (NASDAQ:SSKN) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 4.24M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Strata Skin Sciences, Inc. (NASDAQ:SSKN) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For SSKN, the company currently has 3.94 million of cash on the books, which is offset by 3.57 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 42.9 million in total assets, balanced by 31.29 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Strata Skin Sciences, Inc. (SSKN) saw 351,000 in free cash flow last quarter, representing a quarterly net change in cash of 175,000. Perhaps most importantly where cash movements are concerned, the company saw about 879,000 in net operating cash flow.

Strata Skin Sciences, Inc. (NASDAQ:SSKN) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 8.7 million in total revenues. That represents a quarterly year/year change in revenues of 0.12 in sequential terms, the SSKN saw sales decline by 0.20.

But what about the bottom line? After all, that’s what really matters in the end. Strata Skin Sciences, Inc. (SSKN) is intriguing when broken down to its core data. The cost of selling goods last quarter was 3.17 million, yielding a gross basic income of 5.53 million. For shareholders, given the total diluted outstanding shares of 2.33 million, this means overall earnings per share of -0.52. Note, this compares with a consensus analyst forecast of -0.68 in earnings per share for its next fiscal quarterly report.

Is Strata Skin Sciences, Inc. (NASDAQ:SSKN) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about -0.77 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 9,999. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Strata Skin Sciences, Inc..

Previous ArticleNext Article

Related Post

Should You Buy CarMax Inc. (KMX) or Inc. ... CarMax Inc. (NYSE:KMX) and Inc. (NYSE:CARS) are the two most active stocks in the Auto Dealerships industry based on today’s trading volumes....
Looking at the Big Picture for The Interpublic Gro... The Interpublic Group of Companies, Inc. (NYSE:IPG) is in the highlights and many would want to know whether now might be a good time for it to presen...
Drilling Down Into the Books for Teva Pharmaceutic... Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the more popular stocks investors are adding into their watchlist. Now trading with a mar...
Why Gulfport Energy Corporation (GPOR) Is Being Ad... It's worth it to have a look at Gulfport Energy Corporation (NASDAQ:GPOR) as there may be a chasm between the bulls and the bears as far as recent tra...
Drilling Down Into the Books for Enterprise Produc... Enterprise Products Partners L.P. (NYSE:EPD)'s interesting series of developments are underway around the US stock market these days. Now trading with...